Voloridge Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-29,093
Closed -$174K 1151
2024
Q4
$174K Buy
+29,093
New +$160K ﹤0.01% 1144
2024
Q1
Sell
-51,375
Closed -$252K 1121
2023
Q4
$252K Sell
51,375
-193,820
-79% -$884K ﹤0.01% 1095
2023
Q3
$1.34M Buy
245,195
+51,462
+27% +$340K 0.01% 1035
2023
Q2
$1.3M Sell
193,733
-142,834
-42% -$1.06M 0.01% 1069
2023
Q1
$2.97M Sell
336,567
-71,067
-17% -$627K 0.01% 848
2022
Q4
$3.11M Buy
407,634
+105,880
+35% +$824K 0.02% 838
2022
Q3
$2.15M Buy
301,754
+86,496
+40% +$815K 0.01% 968
2022
Q2
$1.74M Buy
215,258
+130,802
+155% +$1.15M 0.01% 1055
2022
Q1
$1.17M Buy
84,456
+52,863
+167% +$831K 0.01% 1093
2021
Q4
$886K Buy
31,593
+24,475
+344% +$750K ﹤0.01% 1295
2021
Q3
$242K Sell
7,118
-100,859
-93% -$3.65M ﹤0.01% 1562
2021
Q2
$4.41M Sell
107,977
-25,817
-19% -$1M 0.03% 689
2021
Q1
$5.39M Sell
133,794
-89,545
-40% -$4.85M 0.04% 507
2020
Q4
$13.2M Buy
223,339
+123,836
+124% +$6.39M 0.11% 219
2020
Q3
$4.84M Buy
99,503
+77,603
+354% +$3.26M 0.04% 455
2020
Q2
$1.06M Buy
+21,900
New +$798K 0.01% 835

Other funds holding ADPT

Voloridge Investment Management's ADPT Position: Q1 2025 in Review

Voloridge Investment Management sold out of Adaptive Biotechnologies (ADPT) in Q1 2025, closing a stake of 29,093 shares — an estimated $174K sold.

Voloridge Investment Management first reported a position in ADPT in Q2 2020 and held it in 16 quarters. The position peaked at $13.2M in Q4 2020. 225 funds tracked by Wall St. Rank hold ADPT as of Q1 2025.

  • Voloridge Investment Management reported no remaining Adaptive Biotechnologies position as of Q1 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 29,093 Adaptive Biotechnologies shares in Q1 2025, an estimated $174K.
  • Voloridge Investment Management first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 16 quarters.
  • Voloridge Investment Management's Adaptive Biotechnologies position peaked at $13.2M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2025.

Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.